Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Egis reports safe and effective new anxiolytic

Dec. 8, 1997

New antipsychotic reported in development at Merck KGaA

Dec. 4, 1997

S-2474: antiarthritic agent with dual NSAID/DMARD profile

Dec. 4, 1997

New glucocorticoid from Kissei under development for asthma

Dec. 4, 1997

New inhibitor of inflammatory bone resorption presented at Tokyo congress

Dec. 4, 1997

Y-27632: a smooth muscle relaxant that inhibits p160ROCK protein kinase

Dec. 2, 1997

Potent, orally active gpIIb/IIIa receptor antagonist for once-daily administration

Dec. 2, 1997

New anesthetic agent in phase I at Synthelabo

Dec. 1, 1997

Dual-action compound YM-158 shows potential for asthma

Dec. 1, 1997

Esteve presents new calcium antagonists with potential as neuroprotectants

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...